Topics

PAVmed’s PortIO™ Intraosseous Infusion System Achieves Multiple Milestones

04:30 EST 7 Nov 2019 | BioMedReports - Blog

Unprecedented six-month maintenance-free implant duration achieved

FDA pre-submission meeting date supporting de novo application secured

Broad method and device patents granted by USPTO

NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: PAVmed’s PortIO™ Intraosseous Infusion System Achieves Multiple Milestones

NEXT ARTICLE

More From BioPortfolio on "PAVmed’s PortIO™ Intraosseous Infusion System Achieves Multiple Milestones"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...